Document ID: chunk:federal_register_of_legislation:F2025L00062:schedule:1:p39
Version: federal_register_of_legislation:F2025L00062
Segment Type: schedule
Provision Reference: sch 1 (pt 39/51)
Character Range: 119543–122564

500 mg (as hydrochloride)  Oral  Valaciclovir SZ  HX  MP NP     C5961     30  5     30

[170] Schedule 1, Part 1, entry for Valaciclovir in the form Tablet 500 mg (as hydrochloride) [Brand: VALACICLOVIR-WGR; Maximum Quantity: 30; Number of Repeats: 5]
substitute:
Valaciclovir  Tablet 500 mg (as hydrochloride)  Oral  VALACICLOVIR-WGR  WG  MP NP MW  C5940  P5940  30  5     30
Valaciclovir  Tablet 500 mg (as hydrochloride)  Oral  VALACICLOVIR-WGR  WG  MP NP     C5961  P5961  30  5     30

[171] Schedule 1, Part 1, entry for Valaciclovir in the form Tablet 500 mg (as hydrochloride) [Brand: Valtrex; Maximum Quantity: 30; Number of Repeats: 5]
substitute:
Valaciclovir  Tablet 500 mg (as hydrochloride)  Oral  Valtrex  RW  MP NP MW  C5940  P5940  30  5     30
Valaciclovir  Tablet 500 mg (as hydrochloride)  Oral  Valtrex  RW  MP NP     C5961  P5961  30  5     30

[172] Schedule 1, Part 1, entry for Valaciclovir in the form Tablet 500 mg (as hydrochloride) [Brand: Zelitrex; Maximum Quantity: 30; Number of Repeats: 5]
substitute:
Valaciclovir  Tablet 500 mg (as hydrochloride)  Oral  Zelitrex  RF  MP NP MW  C5940  P5940  30  5     30
Valaciclovir  Tablet 500 mg (as hydrochloride)  Oral  Zelitrex  RF  MP NP     C5961  P5961  30  5     30

[173] Schedule 1, Part 1, entry for Vancomycin in the form Powder for injection 500 mg (500,000 I.U.) (as hydrochloride) [Maximum Quantity: 5; Number of Repeats: 0]
substitute:
Vancomycin  Powder for injection 500 mg (500,000 I.U.) (as hydrochloride)  Injection  Vancomycin Viatris  AL  MP MW  C5769  P5769  5  0     1
Vancomycin  Powder for injection 500 mg (500,000 I.U.) (as hydrochloride)  Injection  Vancomycin Viatris  AL  MP     C5716  P5716  5  0     1

[174] Schedule 1, Part 1, entry for Vancomycin in the form Powder for injection 1 g (1,000,000 I.U.) (as hydrochloride) [Maximum Quantity: 3; Number of Repeats: 0]
substitute:
Vancomycin  Powder for injection 1 g (1,000,000 I.U.) (as hydrochloride)  Injection  Vancomycin Viatris  AL  MP MW  C5769  P5769  3  0     1
Vancomycin  Powder for injection 1 g (1,000,000 I.U.) (as hydrochloride)  Injection  Vancomycin Viatris  AL  MP     C5716  P5716  3  0     1

[175] Schedule 1, Part 2, omit entries for Alirocumab
[176] Schedule 1, Part 2, omit entry for Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids and medium chain triglycerides
[177] Schedule 1, Part 2, omit entries for Carmellose
[178] Schedule 1, Part 2, omit entry for Carmellose with glycerin
[179] Schedule 1, Part 2, omit entry for Glucose indicator-urine
[180] Schedule 1, Part 2, omit entries for Niraparib
[181] Schedule 3,
omit table and substitute:
Code  Responsible Person                              ABN
AB    Abbott Australasia Pty Ltd                      95 000 180 389
AE    AFT Pharmaceuticals (AU) Pty Ltd                29 105 636 413
AF    Alphapharm Pty Ltd                              93 002 359 739
AL    Alphapharm Pty Ltd                              93 002 359 739
AN    Amgen Australia Pty